CMMB

CMMB

USD

Chemomab Therapeutics Ltd. American Depositary Share

$2.670-0.080 (-2.909%)

Real-time Price

Healthcare
Biotechnology
Israel

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$2.750

High

$2.790

Low

$2.640

Volume

0.04M

Company Fundamentals

Market Cap

13.9M

Industry

Biotechnology

Country

Israel

Trading Stats

Avg Volume

0.17M

Exchange

NCM

Currency

USD

52-Week Range

Low $2.39Current $2.670High $9.84

Related News

Analyst Upgrades

Oppenheimer Maintains Outperform on Chemomab Therapeutics, Raises Price Target to $25

Oppenheimer analyst Jeff Jones maintains Chemomab Therapeutics with a Outperform and raises the price target from $10 to $25.

View more
Oppenheimer Maintains Outperform on Chemomab Therapeutics, Raises Price Target to $25